NCT07391293 Genetic Aortic Diseases and Cardiovascular Complications. An Observational Survey of Risk Factors.
| NCT ID | NCT07391293 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Policlinico S. Donato |
| Condition | Thoracic Aortic Aneurysm (TAA) |
| Study Type | OBSERVATIONAL |
| Enrollment | 208 participants |
| Start Date | 2025-05-06 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 208 participants in total. It began in 2025-05-06 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this observational study is to define the behavioural and cardiovascular risk factor profiles of patients with genetic aortopathies. The main questions it aims to answer are: * How do the interconnections between lifestyle, stress, psychological condition, perception of illness, and state of health influence each other in this population? * Beyond traditional risk factors, additional emerging factors should be considered, including pregnancy-related complications, sedentary lifestyle, early menopause and depression. The interplay between eating disorders, lifestyle factors and autoimmune or inflammatory bowel diseases remains poorly understood.
Eligibility Criteria
Inclusion Criteria: * signed onformed consent * Ability to speak, read and write in Italian Exclusion Criteria: \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07391293 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, up to 60 Years, studying Thoracic Aortic Aneurysm (TAA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07391293 currently recruiting?
Yes, NCT07391293 is actively recruiting participants. Contact the research team at alessandro.pini@grupposandonato.it for enrollment information.
Where is the NCT07391293 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT07391293 clinical trial?
NCT07391293 is sponsored by IRCCS Policlinico S. Donato. The trial plans to enroll 208 participants.